Immunome, Inc. (NASDAQ:IMNM – Get Free Report) CFO Max Rosett sold 65,000 shares of the stock in a transaction dated Thursday, April 2nd. The stock was sold at an average price of $21.92, for a total transaction of $1,424,800.00. Following the sale, the chief financial officer owned 54,037 shares of the company’s stock, valued at […]

Insmed, Inc. (NASDAQ:INSM – Get Free Report) COO Roger Adsett sold 88,060 shares of Insmed stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $164.63, for a total transaction of $14,497,317.80. Following the transaction, the chief operating officer directly owned 106,810 shares in the company, valued at […]